chr5-1878326-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_016358.3(IRX4):c.1203G>A(p.Ala401Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0905 in 1,558,380 control chromosomes in the GnomAD database, including 7,627 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.12 ( 1612 hom., cov: 34)
Exomes 𝑓: 0.087 ( 6015 hom. )
Consequence
IRX4
NM_016358.3 synonymous
NM_016358.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.70
Genes affected
IRX4 (HGNC:6129): (iroquois homeobox 4) Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in cell development; neuron differentiation; and regulation of transcription by RNA polymerase II. Predicted to act upstream of or within heart development. Predicted to be part of chromatin. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 5-1878326-C-T is Benign according to our data. Variant chr5-1878326-C-T is described in ClinVar as [Benign]. Clinvar id is 1247023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.7 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.233 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IRX4 | NM_016358.3 | c.1203G>A | p.Ala401Ala | synonymous_variant | 5/5 | ENST00000231357.7 | NP_057442.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IRX4 | ENST00000231357.7 | c.1203G>A | p.Ala401Ala | synonymous_variant | 5/5 | 1 | NM_016358.3 | ENSP00000231357.2 |
Frequencies
GnomAD3 genomes AF: 0.122 AC: 18597AN: 152116Hom.: 1607 Cov.: 34
GnomAD3 genomes
AF:
AC:
18597
AN:
152116
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0813 AC: 13068AN: 160656Hom.: 715 AF XY: 0.0804 AC XY: 7030AN XY: 87396
GnomAD3 exomes
AF:
AC:
13068
AN:
160656
Hom.:
AF XY:
AC XY:
7030
AN XY:
87396
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0871 AC: 122428AN: 1406146Hom.: 6015 Cov.: 33 AF XY: 0.0860 AC XY: 59731AN XY: 694594
GnomAD4 exome
AF:
AC:
122428
AN:
1406146
Hom.:
Cov.:
33
AF XY:
AC XY:
59731
AN XY:
694594
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.122 AC: 18630AN: 152234Hom.: 1612 Cov.: 34 AF XY: 0.119 AC XY: 8846AN XY: 74434
GnomAD4 genome
AF:
AC:
18630
AN:
152234
Hom.:
Cov.:
34
AF XY:
AC XY:
8846
AN XY:
74434
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
164
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Pathogenic:1Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 17, 2018 | - - |
See cases Pathogenic:1
Pathogenic, no assertion criteria provided | case-control | Cytogenetics- Mohapatra Lab, Banaras Hindu University | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at